What U-ant does

U-ant Srl is an Italian private company headquartered in Milan that builds and sells ACORP+, a workplace contagion risk management platform aimed at large Italian enterprises. The company was founded on 4 May 2020 during Italy's 'Phase Two' of the Covid-19 pandemic, when approximately 4.4 million workers were returning to work and businesses needed tools to monitor contagion risk. ACORP+ combines per-employee personal scores with environmental scores to produce a systematically updated ranking of personnel by contagion risk and an interactive real-time epidemiological risk map that employers use to drive preventive measures and prioritize medical testing.

The platform is built on proprietary AI algorithms and quantitative models sourced from the Matema research center, which has more than 20 years of experience in machine learning, computational intelligence, and advanced analytics applied to genomics, molecular biology, and socio-economic systems. These methods analyze both structured and non-structured data to produce risk outputs in the microbiology and epidemiology domains. ACORP+ is the company's sole product and is delivered as a customized enterprise solution rather than a self-serve SaaS offering.

U-ant operates a direct enterprise field-sales motion in a single geography (Italy), targeting businesses that bear responsibility for thousands of employees. Revenue is generated through enterprise subscription arrangements with bespoke pricing per client. The company is founder-controlled, co-led by Greta Immobile Molaro (CEO, also CEO of biotech firm Polo GGB) and Vittorio Carlei (Scientific Advisor, also President and Development Director of Matema); no external institutional investors or funding rounds are recorded in the available data, and the company remains at 1-10 employees.

Name

U-ant

Legal name

U-ant Srl

Website

https://uant.eu

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

U-ant is an Italian AI/ML company that sells ACORP+, a workplace contagion risk management platform combining personal and environmental employee scores with real-time epidemiological mapping for large Italian enterprises managing workforce safety during pandemics.

Ownership category

akta.pro rank

Product category

Epidemiological Risk Management Software

NAICS

Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

AI Governance, Risk & Compliance (GRC) Platforms (HDAAAMAA)

akta.pro secondary industry

Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies) (HDAEANAE)

Keywords

• Contagion risk management
• AI risk analytics
• Epidemiological monitoring
• Workplace safety software
• Predictive risk scoring

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. ACORP+ Platform Subscription: Enterprise SaaS platform for contagion risk management provided as a customized solution to businesses. The platform provides ongoing risk monitoring and ranking services for workforce safety.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

U-ant sells the ACORP+ platform, an AI- and machine-learning-based contagion risk management SaaS for large employers. The platform assigns each employee a personal and environmental risk score, producing systematically updated personnel risk rankings and a real-time interactive epidemiological risk map that supports preventive measures and prioritization of medical testing during pandemic conditions such as Covid-19.

Product overview

U-ant is an innovative company born from a research partnership with Matema, a research center specializing in artificial intelligence and machine learning. The company offers a single unified product—the ACORP+ contagion risk management platform—which leverages over 20 years of AI and ML research applied to genomics, molecular biology, and socio-economic systems. ACORP+ is designed for businesses to monitor employee contagion risk during pandemics such as Covid-19, combining personal and environmental risk scoring with real-time epidemiological mapping.

Differentiator

Problem solved

Functional benefit

Brands

• ACORP+: AI-powered contagion risk management platform that provides real-time epidemiological risk mapping and employee risk rankings for workplace safety during pandemic conditions.

Products and services

• ACORP+ Platform Cloud-based AI/ML contagion risk management platform that combines personal and environmental scores for each employee to produce a systematically updated ranking of personnel by contagion risk and an interactive real-time epidemiological risk map, enabling large employers to prioritize medical testing and adopt timely preventive measures during pandemic conditions such as Covid-19.

Quantifiable outcome

• Real-time updated risk rankings enabling timely preventive measures

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature2 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Matema Research CentercoreStrategic or Co-development PartnerMatema is a research center specializing in basic research on artificial intelligence and machine learning algorithms applied to different socio-economic areas. U-ANT was born from a collaborative project with Matema, leveraging their 20+ years of AI and machine learning research to develop the ACORP+ contagion risk management platform.
• Polo GGBminorOthersPolo GGB is a biotech company. Greta Immobile Molaro, CEO of U-ANT, also serves as CEO of Polo GGB, creating a leadership connection between the two companies.

Scale indicators2 records

Recent moves3 records

Expansion highlights4 records

Broad incumbents

• Palantir Technologies: Palantir provides enterprise data and AI platforms used for operational risk, public health, and workforce analytics. It overlaps with U-ant in applying AI to population-level risk scoring and decision support for large institutions.
• ServiceNow: ServiceNow's enterprise workflow platform includes employee health, risk, and compliance modules that overlap with ACORP+. It competes indirectly by allowing large customers to build or buy contagion and workforce risk workflows inside an already-deployed suite.
• Everbridge: Everbridge is a publicly listed critical event management and enterprise resilience platform that includes health, safety, and pandemic-related modules. It competes with ACORP+ for enterprise risk-management budgets and offers overlapping capabilities as part of a broader portfolio.
• C3.ai: C3.ai sells enterprise AI applications including predictive risk and workforce analytics to large organizations. It is comparable because both companies package proprietary AI/ML models into enterprise SaaS sold to large operational buyers.
• Wolters Kluwer (Enablon): Wolters Kluwer owns the Enablon EHS and operational risk platform, which competes with U-ant for enterprise risk software budgets. It is comparable as an established suite player in the same buyer category as ACORP+.

Direct peers

• Intelex Technologies: Intelex provides EHS and quality management SaaS to large enterprises, including workforce risk and incident analytics. Like U-ant, it monetizes ongoing monitoring of employee and workplace risk at large industrial and corporate accounts.
• VelocityEHS: VelocityEHS is a workplace safety and Environmental, Health & Safety (EHS) SaaS platform used by large employers to monitor employee and operational risk. It is comparable to U-ant because both sell enterprise software that continuously scores workforce risk and supports preventive action.
• BlueDot: BlueDot applies AI and machine learning to infectious disease and epidemiological risk intelligence for governments and enterprises. It is the most direct comparable to U-ant's ACORP+ because both use proprietary AI on structured and unstructured data to surface outbreak and contagion risk in operational settings.

Emerging players

• Datavant: Datavant focuses on secure linking and analysis of health and workforce data for enterprises and researchers. It is comparable to U-ant because both build data-infrastructure and analytics products that turn sensitive personal data into actionable enterprise risk insights.
• HealthMap: HealthMap is an academic-origin platform that aggregates and analyzes epidemiological data using automated methods. It is comparable to U-ant's epidemiological risk mapping layer, although HealthMap is more public-health oriented and less enterprise-software oriented.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/u-ant

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about U-ant